PT Siloam International Hospitals Tbk (SILO.JK)
IDR 2950.0
(-2.64%)
IDR 2950.0
(-2.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2098.46 Billion | 1495 Billion | 2033.13 Billion | 1336.6 Billion | 651.5 Billion | 203.64 Billion |
| Net Income | 1211.28 Billion | 696.49 Billion | 674.11 Billion | 116.16 Billion | -338.77 Billion | 16.18 Billion |
| Depreciation & Amortization | 942.29 Billion | 798.5 Billion | 950.43 Billion | 806.82 Billion | 545.85 Billion | 497.9 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 12.38 Billion | 18.78 Billion | 33.7 Billion | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -67.49 Billion | -18.78 Billion | 374.88 Billion | 413.61 Billion | 444.42 Billion | -16.18 Billion |
| Investing Cash Flow | -1427.02 Billion | -1819.03 Billion | -578.37 Billion | -281.67 Billion | -529.15 Billion | -944.33 Billion |
| Investments in PPE | -1427.86 Billion | -1183.23 Billion | -624.63 Billion | -363.94 Billion | -513.81 Billion | -819.3 Billion |
| Acquisitions | 838 Million | -740.17 Billion | 33.66 Billion | 94.87 Billion | -15.53 Billion | -127.2 Billion |
| Investment purchases | - | - | -46.26 Billion | -12.6 Billion | - | - |
| Sales/Maturities of investments | - | - | 12.6 Billion | -94.87 Billion | - | - |
| Other Investing Activities | 2.28 Billion | 104.37 Billion | 46.26 Billion | 94.87 Billion | 189 Million | 2.18 Billion |
| Financing Cash Flow | -530.53 Billion | -740.11 Billion | -448.02 Billion | -462.16 Billion | -23.92 Billion | 25.64 Billion |
| Debt repayment | -225 Billion | -288.55 Billion | -4.38 Billion | -106.5 Billion | -94.49 Billion | -9.39 Billion |
| Dividends payments | -255.25 Billion | -249.9 Billion | -224.59 Billion | - | - | - |
| Common Stock Repurchased | -25.04 Billion | -5.94 Billion | -293.56 Billion | -50.03 Billion | - | - |
| Common Stock Issuance | 30.35 Billion | 12.76 Billion | 3.46 Billion | - | - | -1.99 Billion |
| Other Financing Activities | -55.57 Billion | -208.47 Billion | 71.05 Billion | -305.62 Billion | 70.56 Billion | 35.03 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1079.31 Billion | 1914.51 Billion | 907.53 Billion | 314.06 Billion | 215.92 Billion | 930.13 Billion |
| Cash at end of period | 1199.41 Billion | 1045.57 Billion | 1914.51 Billion | 907.53 Billion | 314.06 Billion | 215.92 Billion |
| Capital Expenditure | -1427.86 Billion | -1183.23 Billion | -624.63 Billion | -363.94 Billion | -513.81 Billion | -819.3 Billion |
| Effect of forex changes on cash | -250 Million | 1.93 Billion | 249 Million | 702 Million | -281 Million | 836 Million |
| Net cash flow / Change in cash | 120.1 Billion | -868.94 Billion | 1006.98 Billion | 593.46 Billion | 98.14 Billion | -714.21 Billion |
| Free Cash Flow | 670.6 Billion | 311.76 Billion | 1408.49 Billion | 972.65 Billion | 137.69 Billion | -615.66 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 320.6 Billion | 300.6 Billion | 13.67 Billion | 352.37 Billion | 1211.28 Billion | 355.53 Billion |
| Depreciation & Amortization | 259.82 Billion | 254.43 Billion | 249.29 Billion | 235.81 Billion | 942.29 Billion | 235.14 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 1.57 Billion | 1.91 Billion | 12.38 Billion | 1.91 Billion |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 359.54 Billion | 477.53 Billion | 627.41 Billion | 231.51 Billion | -67.49 Billion | 131.41 Billion |
| Investing Cash Flow | -238.9 Billion | -472.78 Billion | -529.48 Billion | -437.52 Billion | -1427.02 Billion | -186.04 Billion |
| Investments in PPE | -239.46 Billion | -473.1 Billion | -531.62 Billion | -437.27 Billion | -1427.86 Billion | -187.57 Billion |
| Acquisitions | 552 Million | 2.17 Billion | 289 Million | -257 Million | 838 Million | 1.53 Billion |
| Investment purchases | - | 150 Million | -150 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 552 Million | -2 Billion | 2 Billion | 23 Million | 2.28 Billion | 1.53 Billion |
| Financing Cash Flow | -324.15 Billion | -188.43 Billion | -66.09 Billion | -214.93 Billion | -530.53 Billion | -146.97 Billion |
| Debt repayment | -200 Billion | -200 Billion | -75 Billion | -75 Billion | -225 Billion | -500 Billion |
| Dividends payments | - | -259.64 Billion | - | -1 Million | -255.25 Billion | - |
| Common Stock Repurchased | - | - | -23.72 Billion | -9.16 Billion | -25.04 Billion | -15.88 Billion |
| Common Stock Issuance | 5.48 Billion | 2.78 Billion | 5.13 Billion | 22.68 Billion | 30.35 Billion | -1 Million |
| Other Financing Activities | -129.64 Billion | 202.78 Billion | 80.13 Billion | -153.45 Billion | -55.57 Billion | 384.79 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 846.14 Billion | 996.94 Billion | 1199.41 Billion | 1029.74 Billion | 1079.31 Billion | 624.62 Billion |
| Cash at end of period | 961.52 Billion | 860.12 Billion | 996.94 Billion | 1199.41 Billion | 1199.41 Billion | 1016.86 Billion |
| Capital Expenditure | -239.46 Billion | -473.1 Billion | -531.62 Billion | -437.27 Billion | -1427.86 Billion | -187.57 Billion |
| Effect of forex changes on cash | -1.7 Billion | 669 Million | 541 Million | 219 Million | -250 Million | 1.24 Billion |
| Net cash flow / Change in cash | 115.37 Billion | -136.82 Billion | -202.46 Billion | 169.66 Billion | 120.1 Billion | 392.23 Billion |
| Free Cash Flow | 440.68 Billion | 50.59 Billion | -139.82 Billion | 384.34 Billion | 670.6 Billion | 536.43 Billion |
0IFX
ANGHW
3857
002097
Y92
KSE